PMA device
AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)
Abbott Medical · Leadless Pacemaker (PNJ, Class III) · First FDA decision Aug 15, 2025, newest Aug 15, 2025Bradycardia and heart block
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "AVEIR AR 2"
MAUDE reports
683
Brand "AVEIR AR 2", since 2015
PubMed studies
0
Mentioning "AVEIR AR 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)PMA supplement
P150035-S029 · Decided Aug 15, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Leadless pacemaker (PNJ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Leadless PacemakersNational analysisReview closedCAG-00448NUpdated Sep 18, 2026
- Leadless PacemakersNational determinationOn the books20.8.4Updated Mar 4, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "AVEIR AR 2", any status and sponsor, newest update first.
- LEAP 2 Chronic EFSRecruiting
Abbott Medical DevicesPublic (ABT)
NCT07287423 · 30 participants (planned) · Start Dec 13, 2025 · Primary completion Jul 2027
Device: AVEIR CSP Leadless Pacemaker System · For: Cardiac Pacemaker; Cardiac Rhythm Disorder; Bradycardia
Sites: Prague, Czechia
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AVEIR AR 2", and for the whole product code for context.
This brand
683 reports: 454 malfunction, 220 injury, 9 death
Whole product code PNJ
21,401 reports: 11,736 malfunction, 8,341 injury, 1,319 death
Newest reports for this brand
2017865-2026-22890 · Received Oct 29, 2026 · Event dated Oct 12, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Perforation
- AVEIR AR 2 Leadless PacemakerMalfunction
2017865-2026-22809 · Received Oct 28, 2026 · Event dated Oct 9, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: Use of Device Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AVEIR AR 2 Leadless PacemakerMalfunction
2017865-2026-22826 · Received Oct 28, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Embolism/Embolus
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Merlin" Patient Care System (PCS) software Merlin" PCS 3650 programmer Model 3330 softwareOpen, Classified
Z-2405-2026 · Started May 12, 2026 · Posted by FDA Jun 11, 2026
Reason given: Software malfunction may occur during pacing capture threshold test of pacemaker resulting in programmer not successfully communicating the command to terminate the test.
Cause as FDA categorized it: Software Design Change · Device type: Leadless Pacemaker (PNJ)
- Abbott Aveir Leadless Pacemaker, REF: LSP112V, STERILEEOOpen, Classified
Z-1695-2024 · Started Feb 5, 2024 · Posted by FDA Apr 29, 2024
Reason given: Their is a potential that electromagnetic interference may cause leadless pacemaker may result in mode change.
Cause as FDA categorized it: Device Design · Device type: Leadless Pacemaker (PNJ)
Published research
The most relevant PubMed records for "AVEIR AR 2"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PNJ.
- Aveir Leadless SystemAbbott Medical · PMA 2026
- Aveir VR Leadless SystemAbbott Medical · PMA 2026
- Micra Transcatheter Pacing SystemMedtronic, Inc. · PMA 2026
- Aveir DR Delivery Catheter (LSCD201)Abbott Medical · PMA 2026
- Medtronic Micra Transcatheter Pacemaker SystemMedtronic, Inc. · PMA 2017
- AVEIR VR Real-World Evidence StudyAbbott Medical · PMA 2026
- AVEIR Patient TransmitterAbbott Medical · PMA 2024
- Micra VR2 Transcatheter Pacing SystemMedtronic, Inc. · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.